Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael R Zile Added: 1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had… View more
Author(s): Harriette Van Spall , Gregg Stone Added: 1 year ago
ACC 2024 — Late-breaker host Dr Harriette Van Spall (McMaster University, CA) welcomes Principal Investigator Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, New York, NY, US) to discuss the REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure (NCT03499236) (V-Wave Ltd).The RELIEVE-HF trial aims to assess the safety and efficacy of a new device, the V-Wave… View more
Author(s): Stefan Anker Added: 1 year ago
HFA 24 - Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE) joins us in this succinct interview to outline the findings of the RELIEVE-HF trial (NCT03499236).RELIEVE-HF was designed to evaluate the safety and effectiveness of the V-Wave inter-atrial shunt system to reduce lung congestion in patients with advanced heart failure. 605 participants with New York Heart Association (NYHA)… View more
Research Area(s) / Expertise:

Expertise

Dr Justin Davies is a Senior Research Fellow and Consultant Cardiologist at Imperial College London. He also completed his undergraduate training and continued on to complete his PhD at Imperial after being awarded a British Heart Foundation research fellowship. Now a leading clinical academic in the field of interventional cardiology, Dr Davies has pioneered several new techniques, including… View more
Author(s): Gregg Stone Added: 9 months ago
THT Conference 2025 - Outcomes after heart failure patients were treated with an interatrial shunt show heart failure with reduced ejection fraction (HFrEF) patients had further benefit compared to heart failure with preserved ejection fraction (HFpEF) patients. The study's prediction model revealed four independent predictors of two-year adverse outcomes in HFrEF patients treated with medical… View more
Job title: Clinical Cardiac Electrophysiologist
Dr John Sapp is the Clinical Cardiac Electrophysiologist at the Queen Elizabeth II Health Sciences Centre in Halifax, Canada. At Dalhousie University, Dr Sapp is the Assistant Dean of Clinical Research and Professor of Medicine. At the same institution, he is also cross-appointed to the Department of Physiology and Biophysics. He has previously served as President of the Canadian Heart Rhythm… View more
Author(s): Nicolas M Van Mieghem Added: 1 month ago
NVM Cardiology Conference Reflections: What’s Hot at AHA 2025?Join Prof Nicolas Van Mieghem, Transcatheter Interventions Online Course Director, as he shares his perspective on the most anticipated late-breaking science from AHA 2025; the year’s defining moments in structural, coronary therapeutics.What transformative data should we expect at this year’s meeting? Which studies will challenge… View more
Author(s): Paul Grayburn Added: 5 months ago
Don't miss our late-breaking coverage of New York Valves 2025 Summit, including Expert Interviews offering insights into key data and their future impact on clinical practice. View more